Details for New Drug Application (NDA): 006799
✉ Email this page to a colleague
NDA 006799 describes RUBRAMIN PC, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the RUBRAMIN PC profile page.
The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
Summary for 006799
| Tradename: | RUBRAMIN PC |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | cyanocobalamin |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 010
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Apr 28, 1988 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
